The global fight against cancer requires personalized molecular detection tools to get the right answer the first time.
ArcherDX, Inc. addresses the bottlenecks associated with using next-generation sequencing (NGS) by offering a robust platform for targeted sequencing applications. Improve the speed and accuracy of genetic variant identification and discovery using Archer® patented technology.
Archer patented Anchored Multiplex PCR (AMP™) technology enables:
We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.